Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aida Contreras-Pérez"'
Autor:
Roser López-Alemany, Santi Rello-Varona, Nuria Mulet-Margalef, Xavier Garcia del Muro, Oscar M. Tirado, Miriam Fuentes-Guirado, Silvia Garcia-Monclús, Aida Contreras-Pérez
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Soft-tissue sarcomas (STS) are an uncommon and heterogeneous group of malignancies that result in high mortality. Metastatic STS have very bad prognosis due to the lack of effective treatments. Dinaciclib is a model drug for the family of CDK inhibit
Autor:
Arun Prakash Mishra, Suzanne Hartford, Rajani Kant Chittela, Sounak Sahu, Suhas S. Kharat, Lucia Alvaro-Aranda, Aida Contreras-Perez, Teresa Sullivan, Betty K. Martin, Mary Albaugh, Eileen Southon, Sandra Burkett, Baktiar Karim, Aura Carreira, Lino Tessarollo, Shyam K. Sharan
Publikováno v:
Cell Death and Disease, Vol 14, Iss 11, Pp 1-10 (2023)
Abstract Pathogenic variants in BRCA2 are known to significantly increase the lifetime risk of developing breast and ovarian cancers. Sequencing-based genetic testing has resulted in the identification of thousands of BRCA2 variants that are consider
Externí odkaz:
https://doaj.org/article/4d910d29476842d0a246d375382720ea
Autor:
Santi, Rello-Varona, Miriam, Fuentes-Guirado, Roser, López-Alemany, Aida, Contreras-Pérez, Núria, Mulet-Margalef, Silvia, García-Monclús, Oscar M, Tirado, Xavier, García Del Muro
Publikováno v:
Scientific Reports
Soft-tissue sarcomas (STS) are an uncommon and heterogeneous group of malignancies that result in high mortality. Metastatic STS have very bad prognosis due to the lack of effective treatments. Dinaciclib is a model drug for the family of CDK inhibit